PCRX earnings
Pacira BioSciences (PCRX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
PCRX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | 0.73 | 0.65 | 13.00% | $192.40M |
| Q1 2026 | Apr 30, 2026 | 0.60 | 0.61 | -1.64% | $177.38M |
| Q4 2025 | Feb 26, 2026 | 0.57 | 0.85 | -32.94% | $196.87M |
| Q3 2025 | Nov 6, 2025 | 0.70 | 0.65 | 7.69% | $179.52M |
| Q2 2025 | Aug 5, 2025 | 0.74 | 0.72 | 2.78% | $181.10M |
| Q1 2025 | May 8, 2025 | 0.62 | 0.57 | 8.77% | $168.92M |
| Q4 2024 | Feb 27, 2025 | 0.91 | 0.78 | 16.67% | $187.25M |
| Q3 2024 | Nov 6, 2024 | 0.79 | 0.72 | 9.72% | $168.57M |
| Q2 2024 | Jul 30, 2024 | 0.89 | 0.73 | 21.92% | $178.02M |
| Q1 2024 | May 7, 2024 | 0.62 | 0.64 | -3.13% | $167.12M |
| Q4 2023 | Feb 29, 2024 | 0.89 | 0.89 | 0.00% | $181.24M |
| Q3 2023 | Nov 2, 2023 | 0.72 | 0.84 | -14.29% | $163.93M |
| Aug 2, 2023 | 0.78 | 0.81 | -3.70% | – | |
| May 3, 2023 | 0.53 | 0.60 | -11.67% | – | |
| Feb 28, 2023 | 0.80 | 0.80 | 0.00% | – | |
| Nov 3, 2022 | 0.64 | 0.73 | -12.33% | – | |
| Aug 3, 2022 | 0.51 | 0.85 | -40.00% | – | |
| May 4, 2022 | 0.64 | 0.74 | -13.51% | – | |
| Feb 24, 2022 | 0.97 | 0.83 | 16.87% | – | |
| Nov 3, 2021 | 0.72 | 0.66 | 9.09% | – |
- PCRX reports next on Nov 5, 2026, with EPS of 0.75 expected.
- PCRX beat EPS estimates in 39 of its last 62 reports.
Updated 2026-11-03 11:33 UTC